Professor | 魏继武 | 数字化转型顾问

	Upload Avatar (500 x 500)
Name	魏继武
Contact Information	nwjw@nju.edu.cn
Language ability	中文, 德语
Province	江苏

Upload Avatar (500 x 500)

Name

魏继武

Contact Information

nwjw@nju.edu.cn

Language ability

中文, 德语

Province

江苏

University/Lab Affiliation and Title	南京大学
Faculty	Medical School
Academic Background & Achievements	1993 - 毕业于华中科技大学临床医学德语班 2001 - 暨南大学医学院病理学硕士 2003 - 德国乌尔姆大学医学院博士 2006 - 德国乌尔姆大学医学院博士后 2009 - 德国慕尼黑大学医学院博士后研究员在Cancer Cell, Cancer Res., Int J Cancer, JVI, Nature Comm., Mol Ther., BJC等国际专业期刊发表研究成果获得3项发明专利，申请10项国家发明专利主持4项国家基金及2项省基金课题
Work Experience	1993-2001 - 暨南大学医学院第三附属医院神经外科主治医师 2001-2003 - 德国乌尔姆大学医学院博士研究生 2003-2006 - 德国乌尔姆大学医学院博士后 2007-2009 - 德国慕尼黑大学医学院博士后研究员 2009至今 - 南京大学医学院教授、博导
Awards	2018 - 南京大学“我最喜爱的老师” 2019 - 南京大学“魅力导师”

University/Lab Affiliation and Title

南京大学

Faculty

Medical School

Academic Background & Achievements

1993 - 毕业于华中科技大学临床医学德语班
2001 - 暨南大学医学院病理学硕士
2003 - 德国乌尔姆大学医学院博士
2006 - 德国乌尔姆大学医学院博士后
2009 - 德国慕尼黑大学医学院博士后研究员
在Cancer Cell, Cancer Res., Int J Cancer, JVI, Nature Comm., Mol Ther., BJC等国际专业期刊发表研究成果
获得3项发明专利，申请10项国家发明专利
主持4项国家基金及2项省基金课题

Work Experience

1993-2001 - 暨南大学医学院第三附属医院神经外科主治医师
2001-2003 - 德国乌尔姆大学医学院博士研究生
2003-2006 - 德国乌尔姆大学医学院博士后
2007-2009 - 德国慕尼黑大学医学院博士后研究员
2009至今 - 南京大学医学院教授、博导

Awards

2018 - 南京大学“我最喜爱的老师”
2019 - 南京大学“魅力导师”

Areas of Focus	重组溶瘤病毒介导的溶瘤免疫治疗调控肿瘤炎症和代谢微环境的生物治疗
Publications	Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma, Zuo S, Wei M, Wang S, Dong J, Wei J, 2020 Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma, Meng G, Li B, Chen A, Zheng M, Xu T, Zhang H, Dong J, Wu J, Yu D, Wei J, 2020 Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy, Xia M, Luo D, Dong J, Zheng M, Meng G, Wu J, Wei J, 2019 Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8+ T Cells in HCC, Zhang Y, Zhang H, Wei M, Mou T, Shi T, Ma Y, Cai X, Li Y, Dong J, Wei J, 2019 A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer, Zuo S, Wei M, Zhang H, Chen A, Wu J, Wei J, Dong J, 2019 Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma, Meng G, Fei Z, Fang M, Li B, Chen A, Xu C, Xia M, Yu D, Wei J, 2019 CD8+ T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma, Xu C, Lu X, Liu W, Chen A, Meng G, Zhang H, Li B, Zhang Y, Wu J, Wei J, 2018 Carrier Cells for Delivery of Oncolytic Measles Virus into Tumors: Determinants of Efficient Loading, Xu C, Xia M, Meng G, Li C, Jiang A, Wei J, 2018 The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-κB/IL-6/STAT3 signaling in hepatocellular carcinoma, Lu X, Wo G, Li B, Xu C, Wu J, Jiang C, Wei J NatD promotes lung cancer progression by preventing histone H4 serine phosphorylation to activate Slug expression, Ju J, Chen A, Deng Y, Liu M, Wang Y, Wang Y, Nie M, Wang C, Ding H, Yao B, Gui T, Li X, Xu Z, Ma C, Song Y, Kvansakul M, Zen K, Zhang CY, Luo C, Fang M, Huang DCS, Allis CD, Tan R, Zeng CK, Wei J, Zhao Q, 2017 Oncolytic measles virus enhances antitumour responses of adoptive CD8+NKG2D+ cells in hepatocellular carcinoma treatment, Chen A, Zhang Y, Meng G, Jiang D, Zhang H, Zheng M, Xia M, Jiang A, Wu J, Beltinger C, Wei J, 2017

Areas of Focus

重组溶瘤病毒介导的溶瘤免疫治疗
调控肿瘤炎症和代谢微环境的生物治疗

Publications

Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma, Zuo S, Wei M, Wang S, Dong J, Wei J, 2020
Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma, Meng G, Li B, Chen A, Zheng M, Xu T, Zhang H, Dong J, Wu J, Yu D, Wei J, 2020
Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy, Xia M, Luo D, Dong J, Zheng M, Meng G, Wu J, Wei J, 2019
Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8+ T Cells in HCC, Zhang Y, Zhang H, Wei M, Mou T, Shi T, Ma Y, Cai X, Li Y, Dong J, Wei J, 2019
A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer, Zuo S, Wei M, Zhang H, Chen A, Wu J, Wei J, Dong J, 2019
Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma, Meng G, Fei Z, Fang M, Li B, Chen A, Xu C, Xia M, Yu D, Wei J, 2019
CD8+ T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma, Xu C, Lu X, Liu W, Chen A, Meng G, Zhang H, Li B, Zhang Y, Wu J, Wei J, 2018
Carrier Cells for Delivery of Oncolytic Measles Virus into Tumors: Determinants of Efficient Loading, Xu C, Xia M, Meng G, Li C, Jiang A, Wei J, 2018
The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-κB/IL-6/STAT3 signaling in hepatocellular carcinoma, Lu X, Wo G, Li B, Xu C, Wu J, Jiang C, Wei J
NatD promotes lung cancer progression by preventing histone H4 serine phosphorylation to activate Slug expression, Ju J, Chen A, Deng Y, Liu M, Wang Y, Wang Y, Nie M, Wang C, Ding H, Yao B, Gui T, Li X, Xu Z, Ma C, Song Y, Kvansakul M, Zen K, Zhang CY, Luo C, Fang M, Huang DCS, Allis CD, Tan R, Zeng CK, Wei J, Zhao Q, 2017
Oncolytic measles virus enhances antitumour responses of adoptive CD8+NKG2D+ cells in hepatocellular carcinoma treatment, Chen A, Zhang Y, Meng G, Jiang D, Zhang H, Zheng M, Xia M, Jiang A, Wu J, Beltinger C, Wei J, 2017

溶瘤病毒免疫治疗重组病毒肿瘤炎症代谢微环境生物治疗癌症治疗腺病毒痘苗病毒 Rna治疗

许扬 - 南方科技大学

姜鹏 - 武汉大学

孙华文 - 武汉大学

View All

Personal Information

Academic Information

Research

联系我们

还未创建账户?

Personal Information

Academic Information

Research

联系我们